Pages that link to "Q34224030"

The following pages link to Metabolic syndrome as a risk factor for neurological disorders. (Q34224030):

Displaying 39 items.

• Nutritional Cues Tie Living Organisms to Their Environment and Its Sustainability (Q26738452) (← links)
• Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity (Q26802171) (← links)
• Interactive actions of Bdnf methylation and cell metabolism for building neural resilience under the influence of diet (Q27308276) (← links)
• Dietary fructose aggravates the pathobiology of traumatic brain injury by influencing energy homeostasis and plasticity. (Q30751435) (← links)
• A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. (Q34333249) (← links)
• Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome (Q34461400) (← links)
• A systematic review of behavioural techniques used in nutrition and weight loss interventions among adults with mobility-impairing neurological and musculoskeletal conditions (Q35064207) (← links)
• Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study (Q35950457) (← links)
• Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome (Q36329909) (← links)
• Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation (Q36511191) (← links)
• Cardiometabolic risk factors predict cerebrovascular health in older adults: results from the Brain in Motion study. (Q36846416) (← links)
• Correlation Between the Severity of Diabetic Peripheral Polyneuropathy and Glycosylated Hemoglobin Levels: A Quantitative Study (Q36864575) (← links)
• Systems Nutrigenomics Reveals Brain Gene Networks Linking Metabolic and Brain Disorders. (Q37009081) (← links)
• Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease (Q37177378) (← links)
• Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study (Q37245217) (← links)
• Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks (Q37254592) (← links)
• Towards a 'systems'-level understanding of the nervous system and its disorders (Q37282101) (← links)
• The difference in correlation between insulin resistance index and chronic inflammation in type 2 diabetes with and without metabolic syndrome (Q37304206) (← links)
• Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance (Q37725054) (← links)
• Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (Q38083879) (← links)
• Genomic medicine and risk prediction across the disease spectrum (Q38322338) (← links)
• Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology? (Q38413096) (← links)
• The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment (Q39011807) (← links)
• Chronic airway-induced allergy in mice modifies gene expression in the brain toward insulin resistance and inflammatory responses. (Q42563794) (← links)
• QT dispersion in mild cognitive impairment: a possible tool for predicting the risk of progression to dementia? (Q43405349) (← links)
• Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk (Q47557966) (← links)
• METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. (Q48086135) (← links)
• Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study (Q48212947) (← links)
• Chronic sulforaphane oral treatment accentuates blood glucose impairment and may affect GLUT3 expression in the cerebral cortex and hypothalamus of rats fed with a highly palatable diet (Q50881861) (← links)
• Metabolic syndrome in systemic lupus erythematosus patients : Relationship to disease activity and neuropsychiatric lupus. (Q53693245) (← links)
• Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users (Q60937774) (← links)
• Southern Brazilian native fruit shows neurochemical, metabolic and behavioral benefits in an animal model of metabolic syndrome (Q89036526) (← links)
• Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model (Q89520027) (← links)
• Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer's Disease Cohort (Q89964410) (← links)
• System biology approach intersecting diet and cell metabolism with pathogenesis of brain disorders (Q90613241) (← links)
• Visceral adiposity and insular networks: associations with food craving (Q91014077) (← links)
• Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome (Q91198502) (← links)
• Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism (Q91773883) (← links)
• Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study (Q92180198) (← links)